FDA Says OTC Asthma Inhalers with CFC Banned After Dec 31
The Food and Drug Administration states that users of epinephrine inhalers with chlorofluorocarbon (CFC)-containing epinephrine should plan now to get a prescription for a replacement product because these inhalers will not be made or sold after December 31, 2011. Primatene…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Mist, marketed by Armstrong Pharmaceutical Inc, is the only such FDA-approved over-the-counter inhaler of this type. According to FDA, this action is in accordance with the Montreal Protocol on Substances that Deplete the Ozone Layer and the phase-out date was announced in November 2008.